Traditional Chinese medicine: the “14th five year plan” for the development of traditional Chinese medicine has been issued, which is beneficial to the traditional Chinese medicine industry and pays attention to traditional Chinese medicine + traditional Chinese medicine service companies

Events

On March 29, 2022, the general office of the State Council issued the “14th five year plan” for the development of traditional Chinese medicine.

Ten point interpretation is beneficial to the industrial development of traditional Chinese medicine industry

(1) higher level: the content continues the 13th five year plan and continues to deepen the coverage of traditional Chinese medicine services, pharmaceutical innovation, modernization and internationalization of traditional Chinese medicine. Compared with the 13th five year plan, this is issued by the State Council rather than the administration of traditional Chinese medicine, at a higher level. The inter ministerial Joint Conference Office of the State Council on traditional Chinese medicine is the highest functional implementation subject, strengthen work coordination, and timely study and promote the solution of important problems in the development of traditional Chinese medicine. We can see that one belt, one road, continues to deepen in the field of pharmaceutical innovation, modernization of Chinese medicine and internationalization of Chinese medicine.

(2) wide coverage of traditional Chinese medicine services: encourage the community to run medicine and encourage the grass-roots to popularize traditional Chinese medicine services. All community health service centers and township health centers are equipped with qualified traditional Chinese medicine centers to realize the full coverage of traditional Chinese medicine centers. Encourage social forces to run traditional Chinese medicine at the grass-roots level. Encourage social forces to set up TCM hospitals in the county, develop rehabilitation hospitals and nursing homes (stations) with TCM characteristics, support social forces to set up medical institutions or elderly care institutions with TCM characteristics, rely on TCM institutions to set up internet TCM institutions, support famous and elderly TCM to set up clinics, and support enterprises to set up chain TCM medical institutions, We will ensure that non-profit Chinese medicine medical institutions run by the society and Chinese medicine medical institutions run by the government enjoy the same rights in terms of access and practice. By 2025, 15% of community health service centers and traditional Chinese medicine centers of township health centers will complete the construction of service connotation, 100% of community health service stations and more than 80% of village clinics can provide traditional Chinese medicine services, and 10% of community health service stations and village clinics will set up “traditional Chinese medicine Pavilion”, so as to continuously improve the accessibility and convenience of grass-roots traditional Chinese medicine services. Give full play to the important role of traditional Chinese medicine in the prevention of diseases, the treatment of major diseases and the rehabilitation of diseases.

(3) integrated traditional Chinese and Western medicine: continue to deepen and be included in the assessment. Integrate traditional Chinese and Western medicine into the hospital evaluation of general hospitals and the performance appraisal of public hospitals, promote the establishment of clinical departments of traditional Chinese medicine in all three-level general hospitals, integrate traditional Chinese medicine into the multidisciplinary consultation system, and strengthen the cooperation and collaborative research of traditional Chinese and Western medicine. Strive to form about 100 diagnosis and treatment schemes or expert consensus of integrated traditional Chinese and Western medicine in five years, and promote their use throughout the country.

(4) support minority medicine. Increase policy support for minority medicine.

(5) support the inheritance of traditional Chinese medicine. We will implement a special project for the inheritance of ancient books and documents of traditional Chinese medicine and characteristic technologies, carry out the excavation and publication of ancient books and documents of advantageous diseases of traditional Chinese medicine for clinical use, as well as the screening, evaluation, inheritance and application of characteristic technologies of traditional Chinese medicine.

(6) support the innovation and modernization of traditional Chinese medicine. Build about 30 national traditional Chinese Medicine Inheritance and innovation centers. Strengthen the research and development of new traditional Chinese medicine based on ancient classic prescriptions, famous and old traditional Chinese medicine empirical prescriptions, effective components or components. Support the innovative research and development of Chinese patent medicines for children. Promote the establishment of key technology and equipment projects of traditional Chinese medicine. At the same time, according to the characteristics of traditional Chinese medicine and the degree of registration, the classification of traditional Chinese medicine products has rich basis for the development and registration of traditional Chinese medicine. Build a “Three Combinations” evaluation evidence system. Promote the transformation of traditional Chinese medicine and new drugs in the direction of ancient classic names. Accelerate the organization of research and formulation of key information and textual research opinions of ancient classic famous prescriptions, continue to promote the formulation of the catalogue of ancient classic famous prescriptions, establish a review model suitable for the characteristics of traditional Chinese medicine compound preparations of ancient classic famous prescriptions, establish an expert review committee of traditional Chinese medicine compound preparations of ancient classic famous prescriptions, and implement simplified approval.

(7) price and medical insurance are inclined, and independent pricing + medical insurance payment. The prepared pieces and preparations of traditional Chinese medicine processed and used by medical institutions shall be subject to independent pricing, and those that meet the conditions shall be included in the payment scope of basic medical insurance according to procedures. Select and release more advantageous diseases of traditional Chinese medicine, include them in the category of payment by disease, and encourage the implementation of the same disease, the same effect and the same price of traditional Chinese and Western medicine. We will carry out pilot projects to support the inheritance, innovation and development of traditional Chinese medicine, encourage and promote more local governments and medical insurance departments to try first, and formulate policy documents on medical security to support the inheritance, innovation and development of traditional Chinese medicine.

(8) high quality requirements for traditional Chinese medicine: 1. Strengthen the protection and utilization of traditional Chinese medicine resources. Support the artificial breeding of rare and endangered traditional Chinese medicine. To promulgate and implement the measures for the administration of seeds of traditional Chinese medicine. 2. Strengthen the production and management of genuine medicinal materials. Formulate and release the national catalogue of genuine medicinal materials and build a breeding system of improved varieties of traditional Chinese medicine. 3. Improve the development level of traditional Chinese medicine industry. We will improve the standard system for planting, breeding, warehousing, logistics and primary processing of traditional Chinese medicine. 4. Strengthen the safety supervision of traditional Chinese medicine. Improve the quality evaluation ability of traditional Chinese medicine of drug inspection institutions, establish and improve the safety supervision mechanism of the whole chain of traditional Chinese medicine quality, and build a monitoring system for exogenous harmful residues of traditional Chinese medicine.

(9) financial support: encourage the participation of social capital; One belt, one Road Development Fund for Chinese medicine should be set up and encouraged. Build a number of incubation and transformation bases for scientific and technological achievements of traditional Chinese medicine. Support traditional Chinese medicine hospitals to strengthen cooperation and share resources with enterprises, scientific research institutions and colleges and universities. Encourage colleges and universities, scientific research institutes and medical institutions to establish specialized technology transfer institutions, and give scientific research institutions and researchers greater autonomy in achievement transformation, income distribution and team formation.

(10) talent training. Improve and implement the system of learning traditional Chinese medicine from western medicine. Carry out a nine-year pilot program of integrated traditional Chinese and Western medicine education. Increase the class hours of traditional Chinese medicine courses for clinical medicine majors, list traditional Chinese medicine courses as compulsory courses and graduation internships for undergraduate clinical medicine majors, and increase traditional Chinese medicine knowledge in the qualification examination of clinical doctors. Implement the policy requirements of allowing clinical medical students majoring in traditional Chinese medicine to participate in the qualification examination of integrated traditional Chinese and Western medicine doctors and the standardized training of traditional Chinese medicine doctors.

Investment advice

From a comprehensive perspective, medical services are involved in many aspects, including encouraging society to run hospitals, encouraging stronger and better TCM service institutions, and encouraging social capital to enter; In addition, the traditional Chinese medicine end is beneficial to the varieties with innovation and inheritance, and the innovative drugs and classic prescriptions of traditional Chinese medicine have attracted attention. In addition, on the payment side, traditional Chinese medicine decoction pieces and preparations, integrated traditional Chinese and Western Medicine (encouraging the implementation of the same disease, the same effect and the same price of traditional Chinese and Western Medicine), and encouraging local governments and departments to formulate policy documents to support the inheritance, innovation and development of traditional Chinese medicine. In addition, higher requirements are put forward for the planting end.

Recommended targets (covered) and recommended targets of concern:

Chinese medicine service: gushengtang (covered, buy rating);

Innovative traditional Chinese medicine: Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) (covered, buy rating), Jiangsu Kanion Pharmaceutical Co.Ltd(600557) (covered, buy rating), Guiyang Xintian Pharmaceutical Co.Ltd(002873) (covered, buy rating), Guizhou Sanli Pharmaceutical Co.Ltd(603439) (covered, buy rating), Tasly Pharmaceutical Group Co.Ltd(600535) , Hunan Fangsheng Pharmaceutical Co.Ltd(603998) , etc;

Brand Chinese herbal medicine: brand Chinese herbal medicine:: Tsingtao Brewery Company Limited(600600) 60085 285, Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) , Jiangzhong Pharmaceutical Co.Ltd(600750) , Zhejiang Jolly Pharmaceutical Co.Ltd(300181) , Dong-E-E-Jiao Co.Ltd(000423) , Chongqing Taiji Industry (Group) Co.Ltd(600129) Jiuzhitang Co.Ltd(000989) , Mayinglong Pharmaceutical Group Co.Ltd(600993) , Zhuzhou Qianjin Pharmaceutical Co.Ltd(600479) , Teyi Pharmaceutical Group Co.Ltd(002728) , etc;

Ethnic medicine: Guiyang Xintian Pharmaceutical Co.Ltd(002873) (covered, buy rating), Guizhou Sanli Pharmaceutical Co.Ltd(603439) (covered, buy rating), Guizhou Bailing Group Pharmaceutical Co.Ltd(002424) , Tibet Cheezheng Tibetan Medicine Co.Ltd(002287) , etc;

Chinese herbal medicines: Shanxi Zhendong Pharmaceutical Co.Ltd(300158) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) , Chinese traditional medicine, Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) etc.

Risk tips

Policy uncertainty; Uncertainty of raw material supply fluctuation; Uncertainty about the progress of the epidemic.

- Advertisment -